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The genetic and developmental mechanisms involved in limb formation are relatively well
documented, but how these mechanisms are modulated by changes in chondrocyte
physiology to produce differences in limb bone length remains unclear. Here, we used high
throughput RNA sequencing (RNAseq) to probe the developmental genetic basis of
variation in limb bone length in Longshanks, a mouse model of experimental evolution.
We ﬁnd that increased tibia length in Longshanks is associated with altered expression of a
few key endochondral ossiﬁcation genes such as Npr3, Dlk1, Sox9, and Sfrp1, as well
reduced expression of Fxyd2, a facultative subunit of the cell membrane-bound Na+/K+
ATPase pump (NKA). Next, using murine tibia and cell cultures, we show a dynamic role for
NKA in chondrocyte differentiation and in bone length regulation. Speciﬁcally, we show that
pharmacological inhibition of NKA disrupts chondrocyte differentiation, by upregulating
expression of mesenchymal stem cell markers (Prrx1, Serpina3n), downregulation of
chondrogenesis marker Sox9, and altered expression of extracellular matrix genes (e.g.,
collagens) associated with proliferative and hypertrophic chondrocytes. Together,
Longshanks and in vitro data suggest a broader developmental and evolutionary role
of NKA in regulating limb length diversity.
Keywords: chondrocytes, Na+/K+ ATPase, bone length, Longshanks, growth plate, endochondral ossiﬁcation,
chondrogenesis

INTRODUCTION
The size and shape of skeletal elements, particularly of the limbs, is a key driver of adaptive radiation
in mammals (Smith and Savage, 1956). How variation in the size and shape of limb elements
originates in embryogenesis has been a major focus of evolutionary developmental biology (Müller,
1991). During limb embryogenesis, mesenchymal stem cells (MSCs) initially form condensations in
which the cells eventually differentiate into chondrocytes (Karsenty et al., 2009). These cartilaginous
condensations (anlagen) are subsequently replaced by bone through the process of endochondral
ossiﬁcation (Mackie et al., 2008). Longitudinal growth of the skeletal anlagen occurs within the
growth plate, a highly organized structure that contains a stem cell niche (resting zone) (Abad et al.,
2002), a transit-amplifying zone (proliferative zone), and a differentiation zone in which cells
undergo hypertrophy, producing and remodeling extracellular matrix (hypertrophic zone) (Mackie
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et al., 2008). In the distal growth plate, the terminal fate of
hypertrophic chondrocytes remains unclear: some undergo
programmed cell death, leaving a degraded matrix which is
invaded by vasculature and bone-forming osteoblasts at the
metaphysis, while several recent cell fate mapping studies
show that a portion of these cells can also transdifferentiate
into osteoblasts (Zhou et al., 2014; Cervantes-Diaz et al.,
2017). Heritable length variation within and among bones is
thought to be a product of variation in the initial anlagen size
(Sears et al., 2006; Sanger et al., 2011), in the cellularity and
mitotic activity of the proliferative zone (Kember, 1993; Rolian,
2008; Marchini and Rolian, 2018), and/or in the rate and extent of
hypertrophy in individual hypertrophic cells (Cooper et al., 2013;
Rolian, 2020).
Growth plate organization is conserved across mammals
despite extensive diversity in bone size and proportions both
within and among species (Schmidt and Fischer, 2009). Such a
high degree of conservation in cellular aspects of growth plate
structure indicates that selectable variation in limb bone size and
shape likely has its roots in subtle differences in the genetic
regulation of growth plate development and function.
Progression of chondrocytes through the growth plate is
tightly regulated by several well-characterized signaling
pathways and gene regulatory networks (Karsenty et al., 2009;
Belluoccio et al., 2010; Kozhemyakina et al., 2015). Chondrocytes
of the resting zone are characterized by strong expression of early
mesenchymal fate markers such as Prrx1 and Sox9 as well as
PTHrP (Mizuhashi et al., 2018; Matsushita et al., 2020). As these
chondrocytes enter the proliferative zone, Prrx1 and PTHrP
expression is reduced, and chondrocytes begin to produce
extracellular collagen II and aggrecan as they arrange into
columns, parallel to the direction of elongation (Leung et al.,
2011). Initiation of hypertrophy is accomplished through
increased expression of Runx2 and Mef2C, as well as
downregulation of Sox9, and is accompanied by a change in
extracellular matrix components, most notably a shift in the
predominant forms of collagen from Col2 to Col10
(Kozhemyakina et al., 2015). Spatial organization of this
expression is controlled by several major signaling pathways,
including hedgehog signaling (Ohba, 2016; Haraguchi et al.,
2019), bone morphogenetic protein (BMP) signaling (Nilsson
et al., 2007; Garrison et al., 2017), and Notch signaling (Mead and
Yutzey, 2009b; Zieba et al., 2020). Although it is well understood
how this signaling controls chondrocyte state, it is less clear how
transitions between states are induced and executed at a
molecular and cellular level, and how this can be ﬁnely
modulated to produce normal variation in growth plate activity.
To understand how variation in gene expression in the growth
plate can produce heritable variation in bone length, we
characterized the transcriptome of the proximal tibial growth
plate in the Longshanks mouse. The Longshanks mouse consists
of two mouse lines (LS1 and LS2) selectively bred in parallel for
increased tibia length relative to body mass (Marchini et al.,
2014). After 20 generations of artiﬁcial selection, each
Longshanks line shows a 13–15% increase in tibia length
compared to a random-bred Control line on the same genetic
background (CD-1) while retaining identical body masses
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(Castro et al., 2019). This increase in limb bone length is
observable at birth (Farooq et al., 2017) and appears to be
accomplished primarily through an increase in the number of
proliferative chondrocytes as well as a faster turnover of the
hypertrophic zone (Marchini and Rolian, 2018). Here we show
that both Longshanks lines’ increased tibia length is associated
with a molecular pathway that modulates activity of the Na+/K+
ATPase pump (hereafter NKA pump) by decreasing expression
of its facultative gamma subunit, Fxyd2. Using tissue and
micromass culture, we further demonstrate that modulation of
the NKA pump disrupts chondrocyte differentiation and tibia
growth, revealing a novel and important role for the NKA pump
in controlling progression of chondrocytes through the
growth plate.

MATERIALS AND METHODS
Animal Samples
The study was approved by the University of Calgary Health
Sciences Animal Care Committee (protocols AC13-0077, AC170026). Mice were humanely euthanized and immediately
processed for tissue collection as required by each protocol
(see further). We used mice from different generations of the
Longshanks artiﬁcial selection experiment (Marchini et al., 2014)
for each experiment (see further). The artiﬁcial selection
experiment consists of two lines of mice selectively bred for
increased tibia length with respect to body mass (LS1 and
LS2) and a Control group of random-bred mice from the
same genetic background (CD-1) (Marchini et al., 2014).

RNA Sequencing
Three LS1 and three Control mice from different families in
generation F13 were used for RNA sequencing at 14 days old.
After euthanasia, tibiae from both hindlimbs of several LS1 and
Control mice were dissected, measured and weighed. Then, we
collected the proximal epiphysis of each tibia (consisting of the
growth plate, metaphysis, articular cartilage and secondary
ossiﬁcation center), which were snap-frozen in liquid
nitrogen. The two tibial proximal epiphyses from each mouse
were pooled for total RNA extraction using the RNeasy mini kit
(Qiagen). Before total RNA extraction, the frozen epiphyses
were homogenized using a ball mill (Braun MikroDismembrator S) at 2600 rpm for 60 s. The samples were
then processed and sequenced at the Center for Mouse
Genomics at the University of Calgary. Total RNA-Seq kits
(Life Technologies) were used to obtain Poly-adenylated
mRNAs only from the total RNA and then converted into
bar-coded cDNA libraries. The cDNAs were size selected
using Agencourt AMPure XP beads and then ampliﬁed using
polymerase chain reaction (PCR) to obtain around 50 ng of
240–270 base pairs length cDNAs. Equal amounts of each
library were pooled together. Using the EZ-Bead system (Life
Technologies) magnetic sequencing beads were added to the
libraries. A yield of 2.2 billion beads was obtained. The samples
were then sequenced on a 5500xl Genetic Analyzer (Life
Technologies) to generate 35–50 base paired-end reads.
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RNAseq Data Processing and Analysis

to a manufacture defect of the custom 96-well plates. Outliers
were identiﬁed using SPSS v25 and not considered in subsequent
statistical analysis.

The reads were mapped to the GRCm38 mouse reference genome
(Ensembl Release 84) using HISAT2 v2.0.2 (Kim et al., 2015). In
HISAT2, the options “–ss” and “–exon” were selected and read
counts were created using the software featureCounts v1.4.6.
Read counts were analyzed using DESeq2 (Love et al., 2014),
as proxies for gene expression differences between Control and
LS1. We considered different expression of a transcript to be
signiﬁcant when the p-value, adjusted for false discovery rates,
was less than 0.05. To identify functional groups of differently
expressed genes we used SPIA (Tarca et al., 2009) and the “g
raphite” R package (Sales et al., 2012) together with the Reactome
database (Croft et al., 2014). For additional details on the RNAseq
see https://ucvm-bio.shinyapps.io/Longshanks_RNA-seq/.

Tibia Culture
We harvested embryos at embryonic stage E15.5 from timed
pregnant CD1 females, and placed them in 1x phosphate buffered
saline (PBS) on ice. The tibiae from a minimum of 14 embryos were
dissected under a stereoscope (Olympus SZX12) and placed in
culture media alpha-MEM with the addition of 0.05 g/L ascorbic
acid, 0.108 g/ml β-glycerophosphate, 2 g/L bovine serum albumin,
1000 units/ml of pen-strep, 2.5 ml/L L-Glutamine (Agoston et al.,
2007; Ulici et al., 2008). The media was changed every day for 6 days.
The tibiae were cultured at 37°C and 5% CO2. For each embryo, one
tibia was used as control and the contralateral element was used as
experimental. The only difference between the control and the
experimental bones was the daily addition of either ouabain
octahydrate (Sigma) or monensin sodium salt hydrate (Sigma) in
the media from the second day of culture. We used three different
concentrations of ouabain, 100 µM (n  5), 500 µM (n  5) and
1 mM (n  4), and their respective controls (n  14 pooled), and three
concentrations of monensin, 0.1 µM (n  6), 1 µM (n  5) and 10 µM
(n  6), and their respective controls (n  17 pooled). After 6 days in
culture the tibiae were removed from culture. Specimens were
digitally photographed with a scale at day 0 and at day 6 under
an Olympus SZX12 stereomicroscope using a camera SPOT Insight 2
and pictures were acquired with SPOT imaging software 5.1. We then
took linear measurements of total tibia length using TPSdig2 (Rohlf,
2005). We then processed the tibia for histology or qPCR.

Growth Plate Quantitative RT-PCR
To validate our RNAseq results, we analyzed the gene expression
of the total growth plate (resting, proliferative and hypertrophic
zones) of LS1, LS2 and Control using quantitative reverse
transcriptase polymerase chain reaction (hereafter qPCR).
After euthanasia, ﬁfteen pairs of tibiae from 14-day old mice
from generation F24 were dissected in each line (n  45 mice
total) and placed in RNAlater (Qiagen).
We dissected the proximal tibial total growth plate from both
tibiae under a Zeiss stereomicroscope, and then snap-froze the
growth plates in liquid nitrogen. We pooled the growth plates
from three mice (six total proximal growth plates) to produce ﬁve
biological replicates in each line, and homogenized them using a
ball mill (Braun Mikro-Dismembrator S) at 2600 rpm for 60 s.
We then isolated total RNA using RNeasy mini kit (Qiagen). The
total RNA was then reverse transcribed in cDNA using High
Capacity cDNA Reverse Transcription Kit (Thermo Fisher
Scientiﬁc). We added TaqMan Fast Advance Master Mix
(Thermo Fisher Scientiﬁc) to the samples and qPCR analysis
was performed using custom fast 96-well array plates (Thermo
Fisher Scientiﬁc). The TaqMan assays used were: Actb, C1qtnf3,
Casp1, Col10a1, Col2a1, Ccnb1, Ccnd1, Dlk1, Efemp1, Epyc, Fas,
Fgl2, Frzb, Fxyd2, Gdf10, Hapln1, Igf2, Ihh, Itga1, Matn3, Mest,
Mmp13, Mpeg1, Ptgs2, Pthlh, Runx2, Serpina3n, Sfrp1, Sox9,
Wnt5a, Anxa1, B2m, Bglap3, Bmp2, Casp3, Cox6b1, Ctsc,
Gas5, Mb, Npr3, Parp9, Pdzk1ip1, Wisp3 (Supplementary
Table S1). Genes were selected following an detailed literature
review, in which we searched for genes of interest in combination
with keywords including “chondrocyte,” “growth plate,”
“cartilage,” “bone,” “cell proliferation,” “cell hypertrophy,” and
“cell death.” The plates were read on QuantStudio 6 Flex RealTime PCR System (Thermo Fisher Scientiﬁc) and cycle-tothreshold (CT) was calculated. For each 96 well plate
containing 32 gene primers, we loaded one sample each for
Control, LS1 and LS2. Three technical replicates were
performed for the ﬁrst two biological replicates. Because the
technical replicates of the ﬁrst two biological replicates were
found to have standard deviation less than 0.25, for the other
three biological replicates we performed only two technical
replicates (standard deviation < 0.25). In total, we used ﬁve
plates for the ﬁve biological replicates. Only one gene, Bglap3,
had standard variation > 0.25 in all the plates’ wells, perhaps due
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Tibia Histology
At the end of the culture period, E15.5 tibiae were selected from
control media and from treatments that had the greatest effect on
longitudinal growth (1000 µM ouabain, 0.1 µM monensin), ﬁxed
in 10% NBF and decalciﬁed using Cal-Ex IITM (Fisher
Chemical). Tissues were then dehydrated, embedded in
parafﬁn, and sectioned in the coronal plane at 4 µm. Sections
were deparafﬁnized in xylene and hydrated. Tibia sections were
stained using Wiegert’s Iron Haematoxylin (Sigma), 0.05% FastGreen (FCF) (Sigma) and 0.1% Safranin-o solution (Sigma). The
stained sections were imaged using a digital microscope
(Axioplan 2, Zeiss) with attached camera (Optronics), using
StereoInvestigator v7 or PictureFrame.

Immunohistochemistry
Immunohistochemistry staining was performed as previously
described (Marchini et al., 2019). Brieﬂy, sections of embryonic
tibiae that were treated with the highest concentrations of ouabain
(500 and 1000 µM) were deparafﬁnized, treated with hydrogen
peroxide (15 min, 3% in methanol), followed by membrane
permeabilization and antigen retrieval (30 min, 0.1% Triton-X).
Sections were then blocked with normal serum for an hour at
room temperature and incubated overnight at 4°C with primary
antibody (COLII 1:100, ab34712, AbCam; COLX 1:50, ab49945,
AbCam; DLK1 1:50, 10636-1-AP, ProteinTech; FXYD2 1:20,
11198-1-AP, ProteinTech; KI67 1:100, ab15580, AbCam; NPR3
1:100, ab37617, AbCam; PRRX1 1:100, NBP1-06067, Novus

3

December 2021 | Volume 9 | Article 708384

Na+/K+ ATPase in Endochondral Ossiﬁcation

Marchini et al.

Biologicals, RUNX2 1:400, ab192256, AbCam; SFRP1; 1:100, ab4193,
AbCam; SOX9 1:300, AF3075, Bio-Techne). After washes, sections
were incubated with HRP-conjugated secondary antibodies (SOX9
and PRRX1: Bio-Techne HAF109, 1:100; FXYD2 and RUNX2:
AbCam ab6721; 1:100, COLX: AbCam ab205719, 1:200, all other
primary antibodies: Novus Biologicals NB7160, 1:200) for an hour.
Liquid diaminobenzene (DAB) substrate kit (Invitrogen or DAKO
K346711) was used to detect primary antibodies and methyl green
was used as a counterstain. The stained sections were imaged using
a digital microscope (Axioplan 2, Zeiss) with attached camera
(Optronics), using StereoInvestigator v7 (MBF BioScience,
Williston, VT).

Phasemaker tube (Thermo Fisher Scientiﬁc) following
manufacturer’s protocol. Supernatant was removed and an equal
volume of 70% ethanol was added. This was then added to RNEasy
mini kit column (Qiagen) following the manufacturer’s protocol. The
total RNA was then reverse transcribed in cDNA using HighCapacity cDNA Reverse Transcription Kit (Thermo Fisher
Scientiﬁc). We used TaqMan Fast Advance Master Mix (Thermo
Fisher Scientiﬁc). In the tibia cultures, four tibiae from each
concentration of ouabain and monensin, including controls, were
used. Tibiae qPCR was performed using custom made fast 96-well
plates with primers for 16 genes (Thermo Fisher Scientiﬁc). The 16
TaqMan assays were: 18S, Actb, Bmp2, Casp3, Col2, Col10, Dlk1,
Efemp1, Fasl, Fxyd2, Gdf5, Ihh, Prrx1, Serpina3n, Sox9, and Wnt5a.
Fasl did not amplify in most of the runs and was therefore excluded
from further analyses. For micromass culture, four wells per
concentration of ouabain (each containing 7 masses) were used as
biological replicates. qPCR was performed using 384-well and 96-well
plate using the following TaqMan assays (Thermo Fisher Scientiﬁc):
Actb, Acan, Adamts5, Bcl2, Col2, Col10, Ihh, Mapk14, Mmp13,
Runx2, Sox9. The plates were used on QuantStudio 6 Flex RealTime PCR System (Thermo Fisher Scientiﬁc) and cycle-to-threshold
(CT) was calculated.

Micromass Culture
E11.5 mouse embryos were dissected from timed pregnancies
(Control line females). Fore- and hind limb buds were dissected
on ice in Puck’s Saline A (PSA), and mesenchymal cells were
dissociated in dispase (Dispase II, Sigma Aldrich) in chick serum
at 37°C in an orbital shaker for 30–45 min. Cells were then
resuspended in medium containing 36% Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM), 53% Ham’s nutrient mixture F12, 10%
fetal bovine serum (FBS), 0.5% L-glutamine and 0.5%
streptomycin-penicillin, and plated at high density (2 × 107
cells/mL) in 10 µl droplets in 6-well culture plates (7 droplets/
plate), with daily media changes as previously described (Stanton
et al., 2004; James et al., 2005a; Woods et al., 2005), On day 3,
media was supplemented with β-glycerophosphate and ascorbic
acid to achieve ﬁnal concentrations of 1 and 0.25 mM,
respectively. Serial dilutions of ouabain (ouabain octahydrate,
Sigma-Aldrich) or control vehicle (ddH2O) were introduced at 6,
8 or 10 days to the medium to achieve ﬁnal concentrations of
1 µM, 10 µM, 100 µM and 1 mM ouabain. These time points were
chosen to determine the impact of NKA pump inhibition at
different stages of chondrocyte differentiation. Micromasses were
harvested at selected time points for RNA extraction or histology
(6, 8, 10 and 12 days post-plating, day 15 for histology).

Statistical Analyses
For growth plates, embryonic tibiae, and micromass qPCR, we ﬁrst
calculated the mean cycle-to-threshold (CT) of the technical
replicates for each biological replicate. When we found high
standard deviation (>0.5) in three technical replicates, we excluded
the replicate driving the high deviation. Mean CT was then
normalized using the CT of Actb expression in the same samples,
as a housekeeping gene. Signiﬁcance of differences in normalized
gene expression (deltaCT values) in the growth plates of Control, LS1
and LS2, and in the E15.5 tibia cultures, was determined using
ANOVA, followed by Bonferroni post-hoc test to evaluate pairwise
differences in expression. For micromasses, signiﬁcance of any
differences in gene expression (expressed as deltaCT) was
determined using linear mixed models (LMMs). We used a full
factorial LMM with time point and treatment concentrations
(ouabain or monensin) as categorical factors, and biological
replicate as a random factor. Signiﬁcance of pairwise post-hoc
differences in individual gene expression in micromass assays was
determined using Tukey’s honestly signiﬁcant differences (HSD). All
statistical analyses were performed using SPSS v25 (IBM Corp.
Armonk, NY: IBM Corp), Matlab R2020a (Natick, MA.) or
Statistica v.10 (StatSoft, Tulsa, OK), and were considered
signiﬁcant at p < 0.05.

Micromass Histology
Micromasses harvested for histology at day 15 were washed and ﬁxed
in 3.7% neutral buffered formalin (NBF). After washes in PBS, the
micromasses were treated with 0.2 M hydrochloric acid (HCl) and
stained as follows: 0.1% Alcian Blue in 95% ethyl alcohol (EtOH) for
6.5 h, washed in 70% EtOH, 0.5% KOH for ∼6 min, 1% Alizarin Red
S in PBS at PH  6.3 for 16 h, washed in 70% EtOH, 95% EtOH and
2.0 M HCl. After staining, micromasses were stored and imaged in
glycerol on a digital microscope (AxioPlan 2, Zeiss) with attached
camera (Optronics), using Stereo Investigator v7 (MBF BioScience,
Williston, VT).

RESULTS
Embryonic Tibia and Micromass
Quantitative RT-PCR

Differential Gene Expression Between
Longshanks and Control Using RNA
Sequencing and qPCR

On selected harvest days, micromasses (6–8, 8–10, 10–12 and
6–12 days) and embryonic tibiae (day 6) were washed in PBS,
and stored in Trizol at −80°C for further processing. Tissues were
homogenized using 1.4 mm ceramic beads (VWR) with a Mini Bead
Mill Homogenizer (VWR). Tissue in Trizol was then added to a
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To identify transcriptional differences associated with the
Longshanks phenotype, we compared the gene expression
proﬁle of the proximal tibia between random-bred Control
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TABLE 1 | Genes validated using qPCR.
Symbol

Description

RNAseq and qPCR

Genes from RNAseq analysis with known function(s) in the growth plate
Hapln1
Hyaluronan and proteoglycans link protein 1
↑ LS1
1.0 (0.9–1.2)
LS2
1.1 (0.9–1.2)
Igf2
Insulin like growth factor 2
↑ LS1
1.2 (1.0–1.5)
LS2
1.2 (1.0–1.5)
C1qtnf3
C1q and tumor necrosis factor Related Protein 3 ↑ LS1
1.1 (0.8–1.5)
LS2
1.2 (0.8–1.7)
Dlk1
Delta like non-canonical notch ligand 1
↑ LS1
1.7* (1.3–2.1)
LS2
2.0* (1.5–2.6)
Epyc
Epiphycan
↑ LS1
1.0 (0.9–1.2)
LS2
1.1 (0.9–1.4)
Frzb
Frizzled-related protein
↑ LS1
0.8 (0.6–1.0)
LS2
1.0 (0.8–1.4)
Sfrp1
Secreted frizzled related protein 1
↑ LS1
1.2 (1.0–1.4)
LS2
1.3* (1.1–1.6)
Fgl2
Fibrinogen like 2
↑ LS1
1.1 (0.8–1.4)
LS2
1.3 (1.0–1.7)
Matn3
Matrilin 3
↑ LS1
1.1 (0.8–1.4)
LS2
1.1 (0.8–1.6)
Npr3
Natriuretic peptide receptor 3
↑ LS1
0.5* (0.4–0.6)
LS2
0.6* (0.4–0.8)
Wisp3
WNT1 inducible signalling pathway 3
↑ LS1
1.0 (0.7–1.3)
LS2
1.2 (0.9–1.7)
Bglap3
Bone gamma-carboxyglutamate protein 3
↓ LS1
0.3* (0.2–0.4)
LS2
0.5° (0.3–0.9)
Gdf10
Growth differentiation factor 10
↑ LS1
1.3 (1.1–1.5)
LS2
1.1 (0.9–1.4)
Runx2
Runt related transcription factor 2
↑ LS1
0.9 (0.7–1.1)
LS2
1.2 (1.0–1.4)
Wnt5a
Wnt family member 5a
↑ LS1
0.9 (0.8–1.1)
LS2
0.8 (0.7–0.9)
Col10a1
Collagen type X alpha 1 chain
↑ LS1
0.8 (0.5–1.2)
LS2
0.9 (0.5–1.6)
Mest
Mesoderm speciﬁc transcript
↑ LS1
0.9 (0.8–1.1)
LS2
1.1 (0.9–1.5)
Genes from RNAseq analysis with unknown function(s) in the growth plate
Fas
Fas cell surface death receptor
↑ LS1
1.3 (0.8–2.2)
LS2
1.5 (1.0–2.4)
Anxa1
Annexin A1
↑ LS1
1.3 (0.9–1.8)
LS2
1.2 (0.7–1.8)
B2m
Beta-2-microglobulin
↑ LS1
0.9 (0.7–1.0)
LS2
0.9 (0.8–0.9)
Fxyd2
FXYD domain containing ion transport regulator 2 ↓ LS1
0.4* (0.3–0.5)
LS2
0.3* (0.3–0.4)
Mb
Myoglobin
↓ LS1
1.1 (0.8–1.5)
LS2
1.0 (0.7–1.4)
Efemp1
EGF containing ﬁbulin like extracellular matrix
↑ LS1
1.1 (0.8–1.4)
protein 1
LS2
1.2 (1.0–1.5)
Itga1
Integrin subunit alpha 1
↑ LS1
0.9 (0.7–1.1)
LS2
0.9 (0.8–1.1)
Ptgs2
Prostaglandin-endoperoxide synthase 2
↑ LS1
0.9 (0.6–1.3)
LS2
0.7 (0.5–0.9)
Casp1
Caspase 1
↑ LS1
1.0 (0.6–1.5)
LS2
0.7 (0.5–1.0)
Mpeg1
Macrophage expressed 1
↑ LS1
1.4 (0.6–3.6)
LS2
0.6 (0.5–0.8)
Serpina3n Serpin family A member 3n
↑ LS1
1.2 (0.9–1.5)
LS2
1.3 (1.1–1.5)
Parp9
Poly (ADP-Ribose) polymerase family member 9 ↑ LS1
1.1 (1.0–1.2)
LS2
1.2 (1.0–1.4)
Gas5
Growth arrest speciﬁc 5
↓ LS1
0.6° (0.4–1.0)
LS2
0.8 (0.6–1.1)
Pdzk1ip1
PDZK1 interacting protein 1
↓ LS1
1.0 (0.8–1.3)
LS2
1.4 (1.0–1.9)

Function

Constituent of extracellular matrix (ECM) in resting zone
Growth factor expressed in proliferating chondrocytes
Regulates proliferation and migration of proliferative chondrocytes
Regulates proliferation and differentiation of proliferative chondrocytes
ECM constituent involved in cartilage development and maintenance
Regulates chondrocyte maturation
Wnt antagonist, inhibits hypertrophic differentiation
Hypertrophic marker
ECM protein constituent
Delays chondrocyte hypertrophy
Inhibits chondrocyte hypertrophy
Osteoblast hormone, regulates bone metabolism and energy homeostasis
Inhibits BMP signaling in the proliferative zone
Promotes hypertrophic chondrocyte differentiation
Initiates chondrocyte hypertrophy
Cartilage ECM constituent, expressed in hypertrophic zone
Regulates proliferation and differentiation of proliferative chondrocytes

Promotes programmed cell death
Promotes programmed cell death
Promotes osteoclastogenesis
Regulates efﬁciency of the Na+/K+ ATPase pump
Promotes programmed cell death
ECM constituent in resting zone
Regulates mesenchymal stem cell proliferation
Inhibits cell proliferation and induces programmed cell death
Promotes programmed cell death
Marker of activated macrophages involved in immune response to bacterial
infection
Regulates cell growth and apoptosis
Promotes macrophage activation
Promotes programmed cell death
Inhibits programmed cell death
(Continued on following page)
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TABLE 1 | (Continued) Genes validated using qPCR.
Symbol

Description

RNAseq and qPCR

Cox6b1

Cytochrome C oxidase subunit 6B1

↓

Ctsc

Cathepsin C

↑

Genes not differentially expressed from RNAseq analysis
Sox9
SRY-box 9



Col2a1

Collagen type II alpha 1 chain



Ihh

Indian hedgehog



Mmp13

Matrix metallopeptidase 13



Bmp2

Bone morphogenetic protein 2



Pthlp

Parathyroid hormone-like hormone



Casp3

Caspase 3



Ccnd1

Cyclin D1



Ccnb1

Cyclin B1



LS1
LS2
LS1
LS2

1.0
1.0
1.1
1.1

(0.6–1.5)
(0.6–1.6)
(0.9–1.4)
(0.9–1.3)

LS1
LS2
LS1
LS2
LS1
LS2
LS1
LS2
LS1
LS2
LS1
LS2
LS1
LS2
LS1
LS2
LS1
LS2

0.7° (0.5–1)
0.6* (0.5–0.7)
0.9 (0.6–1.4)
0.9 (0.5–1.7)
0.9 (0.6–1.4)
1.0 (0.6–1.6)
0.9 (0.7–1.1)
0.9 (0.7–1.1)
0.9 (0.7–1.0)
0.9 (0.8–0.9)
1.1 (1.0–1.4)
1.3 (1.0–1.7)
1.0 (0.6–1.6)
1.2 (0.7–1.9)
0.8 (0.6–1)
0.8 (0.6–0.9)
1.3 (1.0–1.7)
1.1 (0.9–1.2)

Function
Involved in mitochondrial respiration
Induces programmed cell death

Delays chondrocyte hypertrophy
Cartilage ECM constituent in proliferative zone
Stimulates chondrocyte proliferation
ECM proteinase expressed in hypertrophic zone
Stimulates chondrocytes hypertrophy
Inhibits chondrocyte hypertrophy
Promotes programmed cell death
Increases proliferation through the G1 phase
Cell proliferation: G2/M phase marker

↑ indicates upregulation in RNAseq.
↓ indicates downregulation in RNAseq method.
 indicates no difference in expression.
LS1 indicates Longshanks Line 1 (n  5 biological replicates).
LS2 indicates Longshanks Line 2 (n  5 biological replicates).
The number after LS1 and LS2 indicates the fold change from qPCR results using the delta-deltaCT method, with 95% conﬁdence intervals estimated from the difference in means and
standard deviations of deltaCT in Longshanks and Controls. Bold font and asterisk indicate statistically signiﬁcant differences from the Control line (n  5 biological replicates) mean at p <
0.05, while bold font and circle indicates p-value p < 0.1 (ANOVA on deltaCT values, Bonferroni post-hoc correction).

and the selectively bred LS1 at 14 days postnatal. Gene
expression data were generated using bulk transcriptomic
sequencing (RNAseq, see Material and Methods for
details). A total of 19,354 genes and their transcript
abundance were mapped using HISAT2(Kim et al., 2015).
We then compared the read counts between Control and LS1
using DESeq2 (Love et al., 2014). We found 421 genes that
were differentially expressed between Control and LS1
(adjusted p-value p < 0.05) (Supplementary Table S2). An
interactive database for comparing expression of all genes
among Longshanks 1 and Control growth plate samples is
available at the following website: https://ucvm-bio.
shinyapps.io/Longshanks_RNA-seq/.
From our initial list of 421 differentially expressed genes, we
then identiﬁed and selected 42 genes with both known and
unknown roles in endochondral ossiﬁcation for validation with
qPCR using complete growth plate tissue, based on a literature
review (see Materials and Methods section for details) (Table 1).
This allowed us to compare broadly between LS1 and LS2, and
limit our comparisons to differences in gene expression to the
growth plate alone, rather than including tissues of the bone
front, epiphysis, and joint surface included in the transcriptomic
analysis. We used Actb as our reference gene to calculate the
difference in PCR cycles-to-thresholds (ΔCT) and relative
quantiﬁcation (fold-change) (James et al., 2005b; Stephens
et al., 2011).
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Only a few genes were differentially expressed in the
Longshanks growth plate (Fxyd2, Dlk1, Npr3, Bglap3, Sfrp1
and Sox9) (Table 1, Supplementary Table S3). Of these, only
Fxyd2, Dlk1, and Npr3 are differentially expressed in both
Longshanks lines. Signiﬁcant differences in Bglap3
(osteocalcin), Sfrp1 and Sox9 are found in only one of the
two lines, although in each case the other line shows a similar
directionality in the change in mean expression relative to
Controls. The greatest observed difference in relative
quantiﬁcation (fold-change) was downregulation of
expression in Fxyd2, which was estimated to be 0.4 times
as high in LS1 and 0.3 in LS2 relative to Controls (Table 1).
Fxyd2 is a facultative gamma subunit of the Na+ /K+ ATPase
pump (NKA pump) which modulates cation afﬁnity of the
pump (Geering, 2008), but a role in endochondral ossiﬁcation
has not previously been described.
Immunohistochemical analyses in proximal tibia epiphyses
indicate that FXYD2 protein is localized primarily to the
proliferative zone and articular cartilage in a spatial pattern
that largely overlaps with expression of the chondrogenic
transcription factor SOX9, (Supplementary Figure S1).
Sox9 is also signiﬁcantly downregulated in LS2, with a
similar trend observed in LS1. Immunostaining against
SOX9 and FXYD2 appears to be weaker and more sparse in
Longshanks vs. Control growth plates (Supplementary
Figures S2A,B) (Agoston et al., 2007). Dlk1 is upregulated,
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FIGURE 1 | Tibiae cultured in ouabain octahydrate. Left: sections of two tibiae from a single E15.5 mouse fetus cultured in 1 mM ouabain (left) and control media
(right), stained with fast green and safranin-o. Black boxes show magniﬁcation of hypertrophic chondrocytes (A, 1 mM ouabain; D, control); proliferative and prehypertrophic chondrocytes (B, 1 mM ouabain; E, control) and epiphyseal/articular cartilage (C, 1 mM ouabain; F, control) Scale bar for magniﬁed areas  50 µm. Right:
Boxplots of negative ΔCT for each gene (y-axis, where increasingly negative values represent lower expression levels relative to the housekeeping gene Actb),
tested at different concentrations of ouabain octahydrate (0 µM or control, 100 µM, 500 µM and 1 mM). Sample size n  4 for all concentrations. For clarity, signiﬁcant
differences between ouabain and vehicle concentrations within gene are not shown, but are reported in Table 2.

whereas Npr3 is downregulated in both LS lines.
Immunostaining against NPR3 suggests that this protein is
less abundant in the proliferative zone in Longshanks
(Supplementary Figure S2C), while DLK1 shows more
intense staining in the resting zone, and in the proliferative
zone including potentially its ECM (Supplementary Figure
S2D). Finally, Sfrp1 is upregulated in LS2, with a similar trend
in LS1, however immunostaining against SFRP1 did not show
any substantive differences in abundance between Control
and Longshanks (Supplementary Figure S2E).

by 40–50% over the 6 days, whereas the tibiae treated with
1000 and 500 µM ouabain increased in length by only
∼15–16%
(Figure
1,
Supplementary
Figure
S3,
Supplementary Table S4). Hence, NKA inhibition by ouabain
was sufﬁcient to suppress longitudinal growth of mouse fetal
tibiae in culture.
Given the reduced longitudinal growth, we asked if, and how,
treatment with ouabain had induced changes in the structure of
the nascent growth plate. Histology showed that in tibiae treated
with 1000 and 500 µM ouabain, the growth plate did not have a
typical proliferative zone with ﬂattened cell columns when
compared to 100 µM ouabain and control media (Figure 1A).
Moreover, proliferative and hypertused previously to
counteractrophic chondrocytes were fewer in number in tibiae
treated with 1000 µM ouabain (Figures 1A,D). In addition, in the
region immediately distal to the hypertrophic cells, the
chondrocytes were present at lower density, with smaller
cytosolic spaces than in control tibiae. Similarly, cells in the
distal epiphysis and articular cartilage of tibiae treated with
1000 µM are small and rounded, without the presence of
cytosolic space observed in the chondrocytes in the same
region in tibiae cultured in control media (Figures 1C,F).
These data suggest that inhibition of the NKA pump with
ouabain inhibits longitudinal growth, potentially by disrupting
progression, differentiation and possibly hypertrophy of
chondrocytes in the growth plate and articular cartilage.
As ouabain appears to interfere with chondrocyte
proliferation, hypertrophy and/or differentiation, we

Inhibition of the NKA Pump Affects Bone
Growth and Chondrocyte Differentiation in
Tibia Organ Cultures
Given the marked differential expression of the facultative NKA
subunit Fxyd2 in our analysis of transcription in the Longshanks
growth plate, we asked whether alterations in NKA function
would impact cellular mechanisms of endochondral ossiﬁcation.
Speciﬁcally, we hypothesized that changing the functionality of
the NKA pump would affect differentiation and/or relevant
physiological processes such as cell swelling/hypertrophy, in
growth plate chondrocytes. To test this, we cultured tibiae
from E15.5 embryos, as well as limb bud micromasses (see
below), in the presence of the cardiac glycoside ouabain
(Nguyen et al., 2007; Sandtner et al., 2011), a known
pharmacological inhibitor of the NKA pump. Tibiae treated
with 100 µM ouabain and control media increased in length
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TABLE 2 | Gene expression in tibia culture using qPCR.
Symbol

Gene name

Bmp2

Bone morphogenetic protein2

Casp3

Caspase 3

Col10a1

Collagen type X alpha 1 chain

Col2a1

Collagen type II alpha 1 chain

Dlk1

Delta like non-canonical notch ligand 1

Efemp1

EGF containing ﬁbulin like extracellular matrix
protein 1

Fxyd2

FXYD domain containing ion transport
regulator 2

Gdf5

Growth differentiation factor 5

Ihh

Indian hedgehog

Prrx1

Paired related homeobox 1

Serpina3n

Serpin family A member 3

Sox9

SRY-box 9

Wnt5a

Wnt family member 5a

Ouabain FC

Monensin FC

1.41 (1.15–1.73)
0.69 (0.58–0.83)
0.64 (0.53–0.77)
1.03 (0.95–1.12)
0.84 (0.73–0.97)
0.81 (0.72–0.92)
0.64 (0.47–0.88)
0.007 (0.002–0.021)
0.004 (0.001–0.011)
0.75 (0.51–1.1)
0.05 (0.02–0.15)
0.02 (0.01–0.03)
1.2 (1–1.43)
1.09 (0.66–1.8)
0.42 (0.32–0.56)
0.4 (0.3–0.52)
0.18 (0.14–0.23)
0.24 (0.16–0.37)
3.21 (2.73–3.76)
4.87 (1.06–22.4)
0.97 (0.44–2.11)
1.16 (0.65–2.07)
0.22 (0.07–0.73)
0.05 (0.03–0.08)
0.96 (0.71–1.29)
0.04 (0.02–0.09)
0.02 (0.01–0.04)
1.97 (1.54–2.52)
2.16 (1.71–2.73)
2.71 (2.28–3.23)
1.67 (1.27–2.19)
9.09 (3.54–23.39)
11.95 (6.57–21.73)
0.94 (0.78–1.12)
0.32 (0.16–0.61)
0.25 (0.21–0.31)
1.73 (1.47–2.04)
0.77 (0.6–0.99)
0.76 (0.61–0.94)

0.87 (0.59–1.28)
0.47 (0.34–0.65)
1.25 (0.81–1.93)
1.07 (0.79–1.45)
0.53 (0.38–0.74)
0.55 (0.41–0.74)
0.05 (0.01–0.28)
0.001 (0.001–0.001)
0.014 (0.003–0.06)
0.53 (0.26–1.09)
0.002 (0.001–0.003)
0.06 (0.02–0.17)
0.73 (0.52–1.03)
0.02 (0.01–0.04)
0.22 (0.14–0.32)
0.6 (0.34–1.05)
0.13 (0.06–0.32)
0.06 (0.02–0.19)
2.74 (1.5–5)
5.53 (3.23–9.46)
5.39 (2.96–9.84)
2.53 (0.53–12.14)
0.04 (0.01–0.14)
0.07 (0.02–0.28)
0.25 (0.09–0.67)
0.01 (0.01–0.02)
0.03 (0.01–0.1)
1.44 (0.96–2.16)
1.14 (0.91–1.42)
0.82 (0.6–1.11)
14.84 (9.74–22.62)
1.23 (0.89–1.7)
0.31 (0.18–0.52)
0.75 (0.44–1.27)
0.19 (0.13–0.27)
0.49 (0.32–0.75)
0.9 (0.55–1.48)
0.29 (0.22–0.39)
0.18 (0.11–0.29)

Function
Stimulates chondrocyte hypertrophy

Promotes programmed cell death

Major cartilage ECM protein, preferentially expressed in
hypertrophic zone
Major cartilage ECM protein, preferentially expressed in
proliferative zone
Regulates proliferation and differentiation of proliferative
chondrocytes
ECM constituent in resting zone and articular cartilage

Modulates efﬁciency of the Na+/K+ ATPase pump

Regulates condensation and differentiation of chondrogenic
precursors
Stimulates chondrocyte proliferation

Mesenchymal stem cell marker

Regulates cell growth and apoptosis

Inhibits chondrocyte hypertrophy

Inhibits chondrocyte hypertrophy

Relative quantiﬁcation or fold changes (FC) in tibiae treated with 100, 500 and 1000 µM ouabain (n  4 each), and 0.1, 1 and 10 µM monensin (n  4 each), listed in increasing order. Values
are mean fold-change in relation to control tibiae, with 95% conﬁdence intervals estimated from the difference in means and standard deviations of deltaCT in treatment and control. Bold
font when there is a minimum of two-fold change (FC) (<0.5 downregulation, >2 upregulation compared to control). Italic font indicates statistically signiﬁcant difference between treatment
concentration and control media at p < 0.05 (ANOVA on deltaCT values, Bonferroni post-hoc).

hypothesized that disruption of the NKA pump’s activity might
interfere with expression of genes with known function in the
growth plate, including genes that are differentially expressed in
Longshanks (Table 1). We collected RNA from whole tibiae
cultured in different concentrations of ouabain and quantiﬁed the
expression of key genes related to chondrogenesis and growth
plate function by qPCR (Table 2 and Supplementary Table S5).
We found that ouabain affects the expression of chondrogenesis
genes in a dose-dependent manner. Culture of tibiae in high
concentrations of ouabain increased expression of the MSC
marker Prrx1 (ten Berge et al., 1998), although its expression
is more sensitive to ouabain and increases even at a concentration
of 100 µM. Conversely, proliferative (Sox9, Dlk1, Col2a1), prehypertrophy (Ihh), and hypertrophy markers (Bmp2, Col10a1,
Gdf5) were downregulated (Coleman and Tuan, 2003; Harkness
et al., 2009; Shu et al., 2011; Usami et al., 2016).
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Markers of cells from the articular cartilage of the joint
surface (Efemp1, Gdf5) also appear to be downregulated,
consistent with the undifferentiated appearance of the
chondrocytes of the joint surface (Figures 1C,F) (Coleman
and Tuan, 2003; Hasegawa et al., 2017). We also found an
increase in expression of SerpinA3n. SerpinA3 protease
inhibitors (anti-chymotrypsins) have been shown to be
expressed in chondrocytes, where they may regulate both
extracellular matrix turnover and cell differentiation (Boeuf
et al., 2008). Ouabain at any concentration does not appear to
increase expression of the cell death marker Casp3 (Porter
and Jänicke, 1999). Interestingly, expression of Wnt5a and
Bmp2 appears to be upregulated at low concentrations of
ouabain, suggesting a dynamic transcriptional response to
NKA pump inhibition. Expression of Fxyd2 does not show
clear directional change across treatments, suggesting that
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inhibition of the NKA pump does not control expression of
this facultative protein.
Next, we validated the qPCR data with immunostaining
against selected proteins. The most consistent differences in
protein expression between control and ouabain-treated tibiae
were seen in the low-density band of cells adjacent to the
hypertrophic chondrocytes in the treated tibiae, and in their
epiphyses (Supplementary Figure S4). In the low cell density
zone, several proteins associated with both proliferation (KI67,
SOX9, COLII, NPR3, SFRP1, DLK1 Supplementary Figures
S4A–F) and hypertrophy (RUNX2, COLX, Supplementary
Figures S4G,H) are present. Immunostaining patterns in this
zone are most similar to the pre-hypertrophic zone in the control
tibia, suggesting that the chondrocytes in this region may be
transitional. Strong immunostaining against the mesenchymal
stem cell marker PRRX1 in this zone in ouabain-treated tibiae
further suggests that these cells maintain or perhaps regain some
pluripotency (Supplementary Figure S4I). In the epiphyses of
control tibiae, all tested proteins are detected except for RUNX2
(Supplementary Figure S4G). In contrast, only COLII, COLX
and FXYD2 are detected in the ouabain-treated epiphyses
(Supplementary Figures S4C,H,J). The smaller lacunae and
absence of most tested proteins suggests the cells in the
treated epiphyses are undifferentiated, or at least not as
metabolically active as they are in control tibiae. While
Collagens II and X proteins are detected in the treated
epiphysis, the staining is reduced compared to Control tibiae,
consistent with the observed qPCR data. FXYD2 protein is
present in the lower hypertrophic zone and epiphysis in
control tibiae, but only in the transitional cells in the treated
tibia, and in its epiphysis (Supplementary Figure S4J).
To further elucidate the potential function of NKA pump
activity in chondrocytes, we performed a complementary
experiment in which we sought to stimulate the pump in tibia
culture. Stimulation of the pump can be achieved indirectly
through increasing Na+ intracellularly using the ionophorous
antibiotic monensin (Hatou et al., 2010; Mendoza et al., 1980;
Petersson et al., 2006; Phornphutkul et al., 2006; Mounier and
Posner, 2006), which has been used previously to counteract the
effects of ouabain (Picton et al., 2017).
We used three different concentrations of monensin: 0.1, 1,
and 10 µM. As in the ouabain cultures, control tibiae increased in
length by ∼40% over 6 days in culture. In contrast, all tibiae
treated with monensin increased in length by ∼25%, irrespective
of the monensin concentration, suggesting that there is no dose
dependence of monensin on tibia growth response, at least not in
the range of concentrations tested (0.1–10 µM) (Supplementary
Figure S3, Supplementary Table S4). Histological sections show
that tibiae cultured in monensin have a disorganized growth plate
without a clear proliferative zone with ﬂat cells organized into
columns. In contrast, the articular cartilage and the hypertrophic
zone are not as strongly affected (Figure 2).
As in the tibiae cultured with ouabain, we collected RNA from
whole tibiae and used qPCR to quantify the expression of the
same genes (Table 2, Supplementary Table S6). We found that,
similarly to ouabain, monensin affects the expression of
chondrogenesis genes. Unlike ouabain cultures, however, the
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relationship between monensin dose and gene expression
appears to be less linear. For example, both Col2a1 and
Col10a1 are downregulated, as well as proliferative markers
(Sox9, Dlk1) and hypertrophy markers (Bmp2, Gdf5), but the
effect of monensin on differential expression of these genes is
greatest at an intermediate concentration (1 µM). Markers of cells
from the articular cartilage of the joint surface (Efemp1, Gdf5)
also appear to be downregulated along with Wnt5a, which
promotes
chondrocyte
columnar
organization
and
hypertrophic differentiation. As with ouabain, monensin does
not appear to increase the cell death marker Casp3. There are a
few notable differences in gene expression between tibiae cultured
in ouabain and monensin: in the latter, Fxyd2 is upregulated in all
concentrations; Serpina3n is upregulated at low dosage while
downregulated at higher concentrations of monensin; and Prrx1
is not differentially expressed. These data suggest that activation
of the NKA pump using monensin has an inhibitory effect on
tibia growth, but this may not be mediated through mesenchymal
cell differentiation.

Inhibition of the NKA Pump Affects
Chondrocyte Size and Differentiation in
Micromass Culture
Because our data shows that ouabain appears to interfere with
chondrocyte proliferation and hypertrophy in tibia culture, we
hypothesized that the effects of inhibiting the NKA pump may be
stage-dependent. To test this, we cultured micromasses derived
from embryonic limb buds and introduced ouabain at different
stages of chondrocytes differentiation, and at four different
concentrations (1, 10, 100, 1000 µM) (Figure 3). We inhibited
the NKA pump in micromasses by introducing ouabain to the
culture medium at different days (Day 6, Day 8, Day 10).
Micromasses were then harvested at different days (Day 8,
Day 10, Day 12). This experimental design allowed us to
inhibit the pump at initiation of chondrocyte proliferation
(6–8 days), during proliferation (8–10 days), and at initiation
of hypertrophy (10–12 days) (James et al., 2005b). We then
extracted RNA, which we quantiﬁed using qPCR for several
key genes involved in chondrocyte differentiation (Figure 3).
As in our tibia culture, we found that culturing cells in higher
concentrations of ouabain decreases expression of Col2a1, when
ouabain is introduced at any stage in differentiation
(Supplementary Table S7). Similarly, high concentrations of
ouabain decrease Col10a1 expression in chondrocytes when
hypertrophic chondrocytes are present (days 10–12). At early
stages (day 6–8), high concentrations of ouabain appear to
decrease expression of Sox9 and Col10a1, although this is not
uniformly statistically signiﬁcant (Figure 3). The matrixmetalloproteinase Mmp13, which mediates extracellular matrix
regulation
of
chondrocyte
terminal
differentiation
(Kozhemyakina et al., 2015), is also upregulated in response to
high ouabain concentrations beginning in early stages (day 6–8)
and even more so at later stages of micromass differentiation (day
8–10 and day 10–12) (Figure 3). In contrast to embryonic tibia
cultures, we did not ﬁnd clear differences in the core matrix
protein aggrecan (Acan), pre-hypertrophy marker Ihh,
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FIGURE 2 | Tibiae cultured in monensin. Left: Sections of two tibiae from a single E15.5 mouse fetus cultured in 0.1 µM monensin (left) and control media (right),
stained with fast green and safranin-o. Black boxes show magniﬁcation of hypertrophic chondrocytes (A, 0.1 µM monensin; D, control); proliferative chondrocytes (B,
0.1 µM monensin; E, control) and articular cartilage (C, 0.1 µM monensin; F, control). Scale bar for magniﬁed areas  50 µm. Right: Boxplots of negative ΔCT for each
gene (y-axis, where increasingly negative values represent lower expression levels relative to the housekeeping gene Actb), tested at different concentrations of
monensin (0 µM or control, 0.1, 1 and 10 µM). Sample size n  4 for all concentrations. For clarity, signiﬁcant differences between ouabain and vehicle concentrations
within gene are not shown, but are reported in Table 2.

changing its afﬁnity for Na+ and K+ ions, and/or for ATP (de
Baaij et al., 2015; Wang et al., 2015). The NKA pump transports 3
Na+ outside of the cell in exchange for 2 K+ using ATP (Castillo
et al., 2015). This exchange of cations between the cell and
interstitial ﬂuid is important to maintain the osmotic stability
and membrane polarity of the cells (Armstrong, 2003).
Previous work has shown that NKA pump subunits are highly
expressed in chondrocytes (Mobasheri et al., 2012), indicating a
potentially important role in chondrocyte physiology and/or
differentiation, but to date that role has not been well
characterized. One role of NKA in chondrocytes could be to
regulate the process of cell swelling associated with hypertrophy,
by regulating osmotic changes across the cell membrane. Our
histological data lend some support to this hypothesis, as
chondrocyte cell size appears to be reduced when the NKA
pump is inhibited in both tibia and cell cultures (Figures 1,
3). We show here that inhibition of the pump with ouabain also
disrupts gene expression associated with normal differentiation of
chondrocytes. Speciﬁcally, well-established markers of
chondrogenic precursors (Prrx1, Serpina3n) (Boeuf et al., 2008;
Liu et al., 2017) are upregulated in tissues and cells cultured in
ouabain, whereas markers of proliferative (Col2a1, Ihh, Sox9),
prehypertrophic (Ihh), and hypertrophic (Col10a1) chondrocytes
are downregulated in these same tissues.
Moreover, consistent and stage-dependent differential
expression of collagen matrix proteins (Col2a1, Col10a1) and
the transcription factor Sox9 suggests that transcriptional
differences are established at the cellular level, and do not

hypertrophic chondrocyte and osteoblast marker Runx2, the
differentiation marker Nf-kB1 (Jimi et al., 2019), or the matrix
degradation marker Adamts5 (Seuffert et al., 2018). As in tibial
culture, we did not observe substantial changes in cell death
markers, here Bcl2 (Wang et al., 2006), but when present, the
changes suggest a decrease in its expression at higher ouabain
concentrations.
We further characterized the histological structure of
micromass colonies after 15 days in culture, with ouabain
introduced at day 6. While at 1 µM concentration there are no
visible differences, micromasses cultured in 10 µM ouabain or
greater are smaller, with fewer smaller and more sparsely
distributed nodules. Moreover, chondrocytes cultured in
higher concentrations of ouabain are smaller and more
densely packed. We also observed that micromass nodules at
higher concentrations of ouabain are surrounded by a denser
calciﬁed matrix as indicated by alizarin red staining
(Supplementary Figure S5).

DISCUSSION
Na+/K+ ATPase Pump in Endochondral
Ossiﬁcation
An unexpected ﬁnding from our comparative RNAseq analysis of
Control and Longshanks tibiae was the strong and consistent
downregulation of Fxyd2 in the latter. Fxyd2 is a gamma subunit
of the NKA pump that modulates activity of the pump by
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FIGURE 3 | Micromasses cultured in ouabain octahydrate. Left: Boxplots of negative ΔCT for each gene (y-axis, where increasingly negative values represent lower
expression levels relative to the housekeeping gene Actb) cultured and harvested at different day ranges (x-axis), and tested at different concentrations of ouabain (0 µM or
control, 1, 10, 100 and 1000 µM). Sample size n  4 for all concentrations. Superscripts denote signiﬁcant pairwise differences among concentrations within a treatment
duration, determined using Tukey’s HSD. Right: Micromasses stained with Alcian blue and alizarin red after 15 days in culture media with 0 µM ouabain (control, top)
and with 10 µM ouabain (bottom), introduced at day 6. Arrows indicate relative size of individual chondrocytes, outlined with a dashed line. Scale bar  100 µm.

simply reﬂect changes in overall number of cells of a given
differentiation state. This pattern is supported by
immunostaining against these three proteins in E15.5 tibiae, as
collagens are generally weaker in both the growth plate and
epiphyses in ouabain-treated tibiae (Supplementary Figures
S4B,C,H). We found a similar response in gene expression after
stimulating the NKA pump using monensin in tibia culture, except
for differences in expression of the prechondrogenic markers Prrx1
and Serpina3n, suggesting that stimulation or inhibition of the
NKA pump in early embryonic tibia contributes to the regulation
of mesenchymal stem cell fate during chondrogenesis. Finally, a
third impact of NKA pump modulation appears to be regulation of
extracellular matrix (ECM) homeostasis (Natoli et al., 2010), as
NKA pump inactivation interferes with expression of collagens in
both proliferative (Col2a1) and hypertrophic (Col10a1)
chondrocytes (see also Supplementary Figures S4C,H), as well
as proteins associated with ECM degradation (Efemp1, Mmp13).
Inferring a speciﬁc pathway or group of pathways by which
NKA disruption may be inducing one or more of these changes in

Frontiers in Cell and Developmental Biology | www.frontiersin.org

chondrocyte and ECM physiology is challenging; the ubiquitous
NKA pump interacts with a number of pathways through ion
transit, by forming complexes with membrane-bound receptors,
and/or by activating a series of kinases (Therien and Blostein,
2000; Tian and Xie, 2008; Reinhard et al., 2013). Of these, we
suggest two possible pathways based on prior work on the NKA
pump in other tissues.
The ﬁrst possibility is that the NKA pump acts directly by
disrupting ion balance across the cell membrane (Cheng et al.,
2019). The NKA pump forms a complex with the Na+–Ca2+
exchanger (NCX) (Tian and Xie, 2008), which can produce
ﬂuctuations in the intracellular concentration of Ca2+, when
exposed to either ouabain (Cheng et al., 2019) or monensin
(Krieger and Tashjian, 1982). These ﬂuctuations in Ca2+ can
facilitate localization of the transcription factor Nf-kB to the
nucleus (Blanco and Wallace, 2013). Nf-kB has been shown to
suppress Sox9 expression (Rockel et al., 2008) and to suppress
differentiation of MSCs into chondrocytes (Sitcheran et al., 2003).
Activation of Nf-kB has also been shown to drive chondrocyte
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hypertrophy (Jimi et al., 2019) as well as osteoblast differentiation
(Mishra et al., 2020). Thus, one possibility is that interfering with the
NKA pump via ouabain or monensin increases intracellular calcium,
leading to increased localization of Nf-kB to the nucleus, regulating
gene expression in the growth plate (e.g., downregulation of Sox9).
A second possibility is that the NKA pump acts through
modulation of a p38-MAPK signaling cascade (Feraille and
Dizin, 2016). Our previous work (Stanton et al., 2004; Agoston
et al., 2007) in micromass culture has shown that p38 signaling plays
an important role in hypertrophic chondrocyte differentiation and
regulates the expression of hypertrophic marker genes such as
Col10a1, Mmp13 and Ibsp. Here, our micromass results show
that, when the NKA pump is inhibited by ouabain, Mapk14
(p38α) expression increases in early stages of chondrocyte
differentiation, with a parallel increase in expression of the ECMrelated Mmp13 that persists through later stages of differentiation
(but a decrease in the expression of Col10a1, Figure 3).

NKA pump both reduced growth in E15.5 tibiae is at odds with
increased tibia growth in Longshanks. These opposite outcomes
may be because Fxyd2 is a facultative subunit of the NKA pump
that modulates its activity in a subtle, cell- and tissue-speciﬁc
manner, while in our tibia culture assays ouabain and monensin
exerted more potent effects on NKA activity across multiple cell
types that inﬂuence bone growth, including chondrocytes,
perichondral/periosteal cells, osteoblasts and/or osteoclasts.
Npr3 (also known as Nprc) is a decoy receptor for C-type
natriuretic peptide (CNP) (Yamashita et al., 2000) CNP is a
known anabolic stimulator of bone growth that promotes
proliferation of chondrocytes (Komatsu et al., 2002; Agoston
et al., 2007; Teixeira et al., 2008; Esapa et al., 2016). Knockout
experiments show that, in absence of Npr3, mice have longer bones
with larger hypertrophic zones comprising both larger and more
numerous chondrocytes, (Komatsu et al., 2002; Agoston et al.,
2007; Teixeira et al., 2008; Esapa et al., 2016). In Longshanks
growth plates, the apparently reduced presence of NPR3 protein in
the proliferative zone (Supplementary Figure S2C) may increase
the bioavailability of CNP, thus stimulating/maintaining
chondrocyte proliferation. Npr3 may also be linked to the
activation of the NKA pump but the exact activation
mechanism is not entirely resolved (Moltzau et al., 2017).
Interestingly, our previous work indicates that Fxyd2 expression
is downregulated in hypertrophic chondrocytes of tibiae cultured
with CNP, suggesting a link between Npr3 and Fxyd2 expression
(Agoston et al., 2007), and therefore a potential link in the
downregulation of these two transcripts in both Longshanks lines.
Dlk1, a non-canonical Notch1 ligand that exists in both transmembrane and soluble forms, is expressed in the proliferative and
resting zones of the growth plate (Supplementary Figure S2D). Dlk1
has been hypothesized to maintain chondrocytes in a proliferative
state, and/or to delay hypertrophic maturation, likely through
interactions with the Notch signaling pathway, an important
regulator of cell differentiation during chondrogenesis (Mead and
Yutzey, 2009a; Chen et al., 2011; Falix et al., 2012; Taipaleenmäki
et al., 2012). In Longshanks, increased gene expression and
immunostaining against DLK1 in chondrocytes in the resting and
proliferative zone (and possibly its ECM, see Supplementary Figure
S2D) is consistent with a potential role in increasing the size of the
proliferative zone and thereby its growth potential (Marchini and
Rolian, 2018; Gerstenfeld and Shapiro, 1996).
Lastly, we found upregulation of Sfrp1 in LS2, and similar trends
in LS1 (Henry et al., 2012). Sfrp1 is expressed in proliferative
chondrocytes and pre-hypertrophic chondrocytes of postnatal
growth plates (Gaur et al., 2006) (see Supplementary Figure
S2E). Sfrp1 is an antagonist of the canonical Wnt/β-catenin
signaling pathway, which induces chondrocyte maturation and
hypertrophy (Dong et al., 2006; Gaur et al., 2006). Although there
were no overt differences in the pattern or intensity of
immunostaining against SFRP1 in Longshanks and Control
growth plates (Supplementary Figure S2E), we suggest that in
Longshanks, increased expression of Sfrp1 in proliferative and prehypertrophic chondrocytes delays their maturation and/or
maintains
their
proliferative
potential.
Interestingly,
upregulation of Sfrp1 is also associated with trabecular bone
deterioration (Wang et al., 2005; Yao et al., 2010; Dy et al.,

Altered Expression of Key Proliferative
Chondrocyte Factors is Associated With
Increased Bone Growth in Longshanks
Our high-throughput transcriptional analysis identiﬁed more than
400 genes with differential expression in the tibial proximal epiphysis
between LS1 and Control. We conducted qPCR in tibial proximal
growth plate cartilage tissue, but were able to validate only a few
genes (out of 42 genes tested) as differentially expressed in LS1
compared to Control. Some differences between the results of the
two methods may be due in part to differences in the tissues sampled;
for RNAseq: we sampled RNA from the total epiphysis, whereas for
qPCR we sampled RNA solely from the growth plate. Hence, we
cannot exclude the possibility that genes differentially expressed in
the bone marrow, articular cartilage, and trabecular bone, and
identiﬁed in our RNAseq analysis, may play an important role in
regulating bone elongation.
Our qPCR results conﬁrm the RNASeq data showing that in both
Longshanks lines three key genes are signiﬁcantly differentially
expressed: Fxyd2 and Npr3 are down-regulated, while Dlk1 is
upregulated. In addition, we ﬁnd signiﬁcant downregulation of
Bglap and Sox9 and upregulation of Sfrp1 in only one of the two
Longshanks lines, although a similar trend can be seen in the other
(Table 1). At ﬁrst glance, it is somewhat unexpected that no other
major chondrogenic factors (e.g., aggrecan, collagens, Ihh, Runx2)
were differentially expressed in Longshanks. One possible reason for
this is that the increased length of the Longshanks tibia is associated
with a larger population of proliferative cells (Marchini and Rolian,
2018). Because the deltaCT method in qPCR normalizes expression
of genes of interest relative to the expression of housekeeping genes, it
effectively normalizes for differences in cell number across samples.
Accordingly, Longshanks may achieve longer tibiae in part by having
more cells which express these speciﬁc chondrogenic factors but at
similar levels to Controls.
Our cell and tissue culture data support a role for the NKA
pump in chondrogenesis and/or endochondral ossiﬁcation.
However, the role of the NKA pump, and Fxyd2 speciﬁcally,
in the accelerated growth and increased length of the Longshanks
tibia, is less clear. The fact that inhibition and stimulation of the
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